Rochester, NY (USA). (January 18, 2017) – Acuity Polymers announced today US FDA clearance for its second gas-permeable (GP) contact lens material available in the US. Acuity 18 is a low Dk fluorosilicone co-polymer for use in custom and specialty GP contact lenses. It has excellent machining and optical properties and is ideally suited where a thin lens profile is preferred or indicated.
“We are very pleased to receive FDA clearance for our second GP material”, said Jim Bonafini, President/COO of Acuity Polymers. “This is the next of numerous products we intend to bring to the US and global markets this year”, he added. “We are thrilled to expand our GP portfolio with Acuity 18, which should serve as an ideal replacement material for lower oxygen transmissibility corneal GP lenses”, added Jonathan Jacobson, CEO of Acuity Polymers.
Acuity 18 GP contact lenses are indicated for daily wear for the correction of refractive error (myopia, hyperopia, presbyopia and/or astigmatism) in aphakic and non-aphakic persons with non-diseased eyes. The lenses may be prescribed for daily wear in otherwise non-diseased eyes that require a rigid contact lens for the management of irregular corneal conditions such as keratoconus, pellucid marginal degeneration, or following penetrating keratoplasty or refractive (e.g., LASIK) surgery.
For more information, please contact Acuity Polymers, Inc. at (888)-POLYMER
or visit them online, www.acuitypolymers.com
About Acuity Polymers:
Acuity Polymers, Inc. was formed in early 2016 to develop contact lens materials and care products geared to specialty contact lens fitters and patients. Based in Rochester, NY, the company received ISO 13485 and ISO 9001 certifications in August of 2016. The company was founded by three contact lens industry professionals (Daniel Bell, J. Bonafini, J. Jacobson) and gratefully financed and supported by contact lens manufacturers inside and outside the US.